highly significantp = 0.002
The difference in the occurrence of systemic amyloidosis between the two groups was highly significant (25% of HP variants patients versus 0% of LP variants patients, p = 0.002).
The difference in the occurrence of systemic amyloidosis between the two groups was highly significant (25% of HP variants patients versus 0% of LP variants patients, p = 0.002).